Furthermore, our study first found that the suppression of ERRα completely reduced the survival of EGF-treated colon cancer cells, though it has been known for many years that ERRα expression is regulated, in part, via the EGF signalling pathway. Here, ESRRA is linked to malignant colon neoplasm.